Home > Drugs A-Z > LANEIGE SATIN FINISH TWIN PACT NO. 21

LANEIGE SATIN FINISH TWIN PACT NO. 21 (AMOREPACIFIC)

Available Formats

Dosage Form Package Information Links
POWDER 13 g in 1 CONTAINER (43419-864-41) Label Information

Complete LANEIGE SATIN FINISH TWIN PACT NO. 21 Information

  • SPL UNCLASSIFIED SECTION

    Drug Facts


  • Active Ingredients

    TITANIUM DIOXIDE 8 %
    ETHYLHEXYL METHOXYCINNAMATE 6 %
    ZINC OXIDE 2.94 %

  • WARNINGS

    For external use only.

    When using this product, Keep out of eyes. Rinse with water to remove.

    Stop use and ask a doctor if rash and irritation develops and lasts.

    Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.


  • Directions

    1. Use after makeup base or foundation.
    2. Tip out the contents with your finger and place on the parts where you want to cover a little bit at a time. Tap it on the part where you want to camouflage.

  • Inactive Ingredients

    TALC, POLYMETHYL METHACRYLATE, DIISOSTEARYL MALATE, ALUMINA, DIMETHICONE, TRIETHOXYCAPRYLYLSILANE, METHICONE, MAGNESIUM STEARATE, ALUMINUM STEARATE, ACRYLATES/TRIDECYL ACRYLATE/TRIETHOXYSILYLPROPYL METHACRYLATE/DIMETHICONE METHACRYLATE COPOLYMER, SYNTHETIC FLUORPHLOGOPITE, WATER, BUTYLENE GLYCOL, BEESWAX, POLYGLYCERYL-3 METHYLGLUCOSE DISTEARATE, INULIN LAURYL CARBAMATE, HYDROXYPROPYL BISPALMITAMIDE MEA, METHYLPARABEN, BUTYLPARABEN, FRAGRANCE, MICA, TITANIUM DIOXIDE (CI 77891), IRON OXIDES (CI 77491, CI 77492, CI 77499), ULTRAMARINES (CI 77007)


  • SPL UNCLASSIFIED SECTION

    13 g / 0.5 OZ. e

    AMOREPACIFIC US INC.
    270 Sylvan Ave. #255
    Englewood Cliffs, NJ07632
    MADE IN KOREA
    (5240)


  • PRINCIPAL DISPLAY PANEL - 13 g Carton Label, No. 13

    LANEÍGE

    SATIN FINISH TWIN PACT
    SPF25 PA++

    PRINCIPAL DISPLAY PANEL - 13 g Carton Label, No. 13

  • PRINCIPAL DISPLAY PANEL - 13 g Carton Label, No. 21

    LANEÍGE

    SATIN FINISH TWIN PACT
    SPF25 PA++

    PRINCIPAL DISPLAY PANEL - 13 g Carton Label, No. 21

  • PRINCIPAL DISPLAY PANEL - 13 g Carton Label, No. 23

    LANEÍGE

    SATIN FINISH TWIN PACT
    SPF25 PA++

    PRINCIPAL DISPLAY PANEL - 13 g Carton Label, No. 23

  • PRINCIPAL DISPLAY PANEL - 13 g Carton Label, No. 25

    LANEÍGE

    SATIN FINISH TWIN PACT
    SPF25 PA++

    PRINCIPAL DISPLAY PANEL - 13 g Carton Label, No. 25

  • PRINCIPAL DISPLAY PANEL - 13 g Carton Label, No. 31

    LANEÍGE

    SATIN FINISH TWIN PACT
    SPF25 PA++

    PRINCIPAL DISPLAY PANEL - 13 g Carton Label, No. 31

  • INGREDIENTS AND APPEARANCE
    LANEIGE SATIN FINISH TWIN PACT NO. 13 
    titanium dioxide, octinoxate, and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:43419-863
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 0.08 mg  in 1 g
    OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 0.06 mg  in 1 g
    ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE 0.0294 mg  in 1 g
    Inactive Ingredients
    Ingredient Name Strength
    TALC (UNII: 7SEV7J4R1U)  
    ALUMINUM OXIDE (UNII: LMI26O6933)  
    DIMETHICONE (UNII: 92RU3N3Y1O)  
    OCTYLTRIETHOXYSILANE (UNII: LDC331P08E)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    ALUMINUM STEARATE (UNII: U6XF9NP8HM)  
    WATER (UNII: 059QF0KO0R)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    YELLOW WAX (UNII: 2ZA36H0S2V)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    BUTYLPARABEN (UNII: 3QPI1U3FV8)  
    MICA (UNII: V8A1AW0880)  
    FERRIC OXIDE RED (UNII: 1K09F3G675)  
    FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
    FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:43419-863-40 13 g in 1 CONTAINER
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH NOT FINAL part352 12/01/2010
    LANEIGE SATIN FINISH TWIN PACT NO. 21 
    titanium dioxide, octinoxate, and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:43419-864
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 0.08 mg  in 1 g
    OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 0.06 mg  in 1 g
    ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE 0.0294 mg  in 1 g
    Inactive Ingredients
    Ingredient Name Strength
    TALC (UNII: 7SEV7J4R1U)  
    ALUMINUM OXIDE (UNII: LMI26O6933)  
    DIMETHICONE (UNII: 92RU3N3Y1O)  
    OCTYLTRIETHOXYSILANE (UNII: LDC331P08E)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    ALUMINUM STEARATE (UNII: U6XF9NP8HM)  
    WATER (UNII: 059QF0KO0R)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    YELLOW WAX (UNII: 2ZA36H0S2V)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    BUTYLPARABEN (UNII: 3QPI1U3FV8)  
    MICA (UNII: V8A1AW0880)  
    FERRIC OXIDE RED (UNII: 1K09F3G675)  
    FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
    FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:43419-864-41 13 g in 1 CONTAINER
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH NOT FINAL part352 12/01/2010
    LANEIGE SATIN FINISH TWIN PACT NO. 23 
    titanium dioxide, octinoxate, and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:43419-865
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 0.08 mg  in 1 g
    OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 0.06 mg  in 1 g
    ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE 0.0294 mg  in 1 g
    Inactive Ingredients
    Ingredient Name Strength
    TALC (UNII: 7SEV7J4R1U)  
    ALUMINUM OXIDE (UNII: LMI26O6933)  
    DIMETHICONE (UNII: 92RU3N3Y1O)  
    OCTYLTRIETHOXYSILANE (UNII: LDC331P08E)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    ALUMINUM STEARATE (UNII: U6XF9NP8HM)  
    WATER (UNII: 059QF0KO0R)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    YELLOW WAX (UNII: 2ZA36H0S2V)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    BUTYLPARABEN (UNII: 3QPI1U3FV8)  
    MICA (UNII: V8A1AW0880)  
    FERRIC OXIDE RED (UNII: 1K09F3G675)  
    FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
    FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:43419-865-42 13 g in 1 CONTAINER
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH NOT FINAL part352 12/01/2010
    LANEIGE SATIN FINISH TWIN PACT NO. 25 
    titanium dioxide, octinoxate, and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:43419-866
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 0.08 mg  in 1 g
    OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 0.06 mg  in 1 g
    ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE 0.0294 mg  in 1 g
    Inactive Ingredients
    Ingredient Name Strength
    TALC (UNII: 7SEV7J4R1U)  
    ALUMINUM OXIDE (UNII: LMI26O6933)  
    DIMETHICONE (UNII: 92RU3N3Y1O)  
    OCTYLTRIETHOXYSILANE (UNII: LDC331P08E)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    ALUMINUM STEARATE (UNII: U6XF9NP8HM)  
    WATER (UNII: 059QF0KO0R)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    YELLOW WAX (UNII: 2ZA36H0S2V)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    BUTYLPARABEN (UNII: 3QPI1U3FV8)  
    MICA (UNII: V8A1AW0880)  
    FERRIC OXIDE RED (UNII: 1K09F3G675)  
    FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
    FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:43419-866-43 13 g in 1 CONTAINER
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH NOT FINAL part352 12/01/2010
    LANEIGE SATIN FINISH TWIN PACT NO. 31 
    titanium dioxide, octinoxate, and zinc oxide powder
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:43419-867
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 0.08 mg  in 1 g
    OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 0.06 mg  in 1 g
    ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE 0.0294 mg  in 1 g
    Inactive Ingredients
    Ingredient Name Strength
    TALC (UNII: 7SEV7J4R1U)  
    ALUMINUM OXIDE (UNII: LMI26O6933)  
    DIMETHICONE (UNII: 92RU3N3Y1O)  
    OCTYLTRIETHOXYSILANE (UNII: LDC331P08E)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    ALUMINUM STEARATE (UNII: U6XF9NP8HM)  
    WATER (UNII: 059QF0KO0R)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    YELLOW WAX (UNII: 2ZA36H0S2V)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    BUTYLPARABEN (UNII: 3QPI1U3FV8)  
    MICA (UNII: V8A1AW0880)  
    FERRIC OXIDE RED (UNII: 1K09F3G675)  
    FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
    FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:43419-867-44 13 g in 1 CONTAINER
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH NOT FINAL part352 12/01/2010
    Labeler - AMOREPACIFIC (687995683)
    Establishment
    Name Address ID/FEI Business Operations
    AMOREPACIFIC 687995683 MANUFACTURE